No Data
A Quick Look at Today's Ratings for Crinetics(CRNX.US), With a Forecast Between $60 to $80
On May 23, major Wall Street analysts update their ratings for $Crinetics(CRNX.US)$, with price targets ranging from $60 to $80.Morgan Stanley analyst Jeffrey Hung maintains with a buy rating, and adj
HC Wainwright & Co. Reiterates Buy on Crinetics Pharmaceuticals, Maintains $60 Price Target
HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals with a Buy and maintains $60 price target.
Morgan Stanley Raises Price Target on Crinetics Pharmaceuticals to $70 From $50, Maintains Overweight Rating
Crinetics Pharmaceuticals (CRNX) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $47 to $97.
Crinetics Pharmaceuticals Inc: Baird raises price target from $52 to $62
Crinetics Pharmaceuticals Inc: Baird raises price target from $52 to $62
Express News | Crinetics Pharmaceuticals Inc : Baird Raises Target Price to $62 From $52
Analysts Are Bullish on These Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Lipella Pharmaceuticals, Inc. (LIPO)